Posts Tagged ‘fda-news’


 Powered by Max Banner Ads 

Joint action is first step in halting sale of the products. The U.S. Food and Drug Administration and the Federal Trade Commission (FTC) today issued seven Warning Letters to companies marketing over-the counter (OTC) HCG products that are labeled as “homeopathic” for weight loss.

Tuesday, December 6th, 2011 at 21:53 | 0 comments
Categories: General

Aside from plastic surgery, Botox has been the best anti-aging weapon up until now.

Monday, October 31st, 2011 at 19:55 | 0 comments

U.S. drug regulators approved Allergan’s Botox for treating a specific kind of overactive bladder on Wednesday, setting the stage for wider use of the popular wrinkle treatment in those with bladder problems. The U.S.

Thursday, August 25th, 2011 at 16:53 | 0 comments

The Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA, Merz Aesthetics) for temporary improvement of moderate to severe glabellar lines, Medscape Today reports. According to a Merz statement, the approval is based on the results of two multicenter U.S.

Wednesday, July 27th, 2011 at 15:54 | 0 comments

–Represents R&D Breakthrough in Commitment to Animal-Free Stability and Potency Testing for BOTOX® and BOTOX® Cosmetic–   IRVINE, Calif.–(BUSINESS WIRE)– Allergan, Inc.

Thursday, June 30th, 2011 at 20:37 | 0 comments

Sunscreen labels will carry a “broad spectrum” label to show they offer some protection against UVA radiation as well as UVB radiation, according to a long-awaited new rule from the FDA.

Tuesday, June 14th, 2011 at 20:04 | 0 comments

Cutera Inc , which makes lasers for medical and aesthetic use, said U.S.

Friday, April 8th, 2011 at 19:44 | 0 comments

A popular type of weight-loss products, heavily promoted on the Internet, is fraudulent and illegal, Food and Drug Administration officials say.

Friday, February 4th, 2011 at 20:46 | 0 comments

Arena Pharmaceuticals said early Saturday morning that the FDA won’t approve the company’s weight-loss drug lorcaserin without further data to support the drug’s efficacy and safety.

Thursday, November 18th, 2010 at 19:30 | 0 comments

Abbott’s removal of Meridia from the U.S. market — at the FDA’s request — means there’s just one weight-loss therapy approved for long-term use in a country where 68% of the population is overweight or obese . (As the WSJ reports, Abbott also pulled the drug in Canada and Australia today.

Thursday, November 18th, 2010 at 19:23 | 0 comments
TOP
SEO Powered by Platinum SEO from Techblissonline